全文获取类型
收费全文 | 145篇 |
免费 | 18篇 |
专业分类
儿科学 | 4篇 |
妇产科学 | 3篇 |
基础医学 | 27篇 |
临床医学 | 14篇 |
内科学 | 53篇 |
皮肤病学 | 2篇 |
神经病学 | 2篇 |
外科学 | 7篇 |
综合类 | 2篇 |
预防医学 | 13篇 |
眼科学 | 1篇 |
药学 | 24篇 |
中国医学 | 2篇 |
肿瘤学 | 9篇 |
出版年
2022年 | 4篇 |
2021年 | 5篇 |
2019年 | 7篇 |
2018年 | 6篇 |
2017年 | 7篇 |
2016年 | 4篇 |
2015年 | 8篇 |
2014年 | 10篇 |
2013年 | 12篇 |
2012年 | 18篇 |
2011年 | 14篇 |
2010年 | 4篇 |
2009年 | 11篇 |
2008年 | 7篇 |
2007年 | 7篇 |
2006年 | 6篇 |
2005年 | 3篇 |
2004年 | 14篇 |
2003年 | 7篇 |
2002年 | 4篇 |
2001年 | 1篇 |
1997年 | 1篇 |
1991年 | 1篇 |
1987年 | 1篇 |
1981年 | 1篇 |
排序方式: 共有163条查询结果,搜索用时 15 毫秒
1.
2.
We describe herein the rare case of a hydatid cyst found in the breast of a 26-year-old woman. Clinically, the mass was at
first suspected of being a fibroadenoma, but fine needle aspiration cytology (FNAC) yielded clear fluid only. Histopathologic
examination of the resected speciman confirmed that it was a hydatid cyst. 相似文献
3.
4.
Bijay Vaidya Brian K Shenton Susan Stamp Margaret Miller Elizabeth Baister Christopher D Andrews A Jane Dickinson Petros Perros Pat Kendall-Taylor 《Thyroid》2005,15(9):1073-1078
Thyroid-associated ophthalmopathy (TAO) is thought to be a T-cell-mediated autoimmune disorder. We sought to characterize abnormalities in the peripheral blood T-cell subsets in patients with TAO, and examine whether the long-acting somatostatin analogue, octreotide-LAR, treatment affects these cells. We analyzed peripheral blood T-cell subsets by flow cytometry in 26 euthyroid patients with moderately severe active TAO and 24 controls. Twenty-five of the patients with TAO were enrolled in a randomized trial to receive either 30 mg of octreotide-LAR (n = 11) or placebo (n = 14) every 4 weeks for 16 weeks; all 25 patients subsequently received octreotide-LAR 30 mg every 4 weeks from week 16 to 32. T-cell subsets were analysed at baseline, week 16, and week 32. At baseline, the relative percentage of CD4+ helper T-cells (p = 0.0003) and the CD4+/CD8+ ratio (p = 0.008) were significantly higher in patients with TAO compared to controls. Patients with TAO had higher na?ve active T cells (CD45RA+, CD45RA+ CD4+) and lower memory T cells (CD45RO+, CD45RO+ CD4+) than controls. At weeks 16 and 32, there were no significant differences in any T-cell subsets between the octreotide-LAR-treated and placebo groups. These results support a role of T cell in the pathogenesis of TAO, and show that octreotide-LAR has no effect on T-cell subsets during 32-weeks of treatment. 相似文献
5.
Zeba N. Singh Yogesh Jethava Ginell R. Post Daisy Alapat Jeffrey Sawyer Sarah Waheed Bijay Nair Saad Z. Usmani Clyde Bailey Nathan Petty Frits Van Rhee Bart Barlogie 《Clinical Case Reports》2015,3(3):183-192
Assiduous surveillance for genetic aberrations is necessary in patients on cytotoxic therapies to detect therapy‐related myeloid neoplasms (t‐MN). Current modalities include metaphase cytogenetics and FISH. Since t‐MN may develop abruptly in cytogenetically normal patients, a discussion exploring additional methods such as SNP‐array and targeted‐deep‐sequencing to detect subchromosomal abnormalities is needed. 相似文献
6.
Indu Javeri Kaliappanadar Nellaiappan Charles McNemar Kirill Yakovlevsky Amina Soukrati Phanindra Velisetty Bijay Misra 《Pharmaceutical research》2018,35(9):168
Purpose
Accurate quantification of the intact proteins, antibodies or peptides and their impurities without interaction to silanols of HPLC column.Methods
Hydroxypropyl ß Cyclodextrin (HPCD) is added in the mobile phase at different concentrations. Different commercial SEC-HPLC columns and biologics with a molecular weight ranging from 5.8 kDa to 150kDa were assessed with and without cyclodextrin.Results
Addition of non-ionic sugars such as Hydroxypropyl ß Cyclodextrin in the mobile phase, resulted improved peak performance such as theoretical plates, peak resolution, peak width, peak height, and improved quantification of aggregates in biologics such as antibodies Humira and Actemra, and peptides such as insulin. There is an increase in peak height, reduced retention time, increased plate and reduced peak width with increasing concentration of cyclodextrin studied.Discussion
High ionic strength, basic amino acids such as arginine, organic solvents (with a concentration low enough not to precipitate protein), sodium perchlorate and ion pairing agents in the mobile phase used for separation of peptides, proteins and antibodies to prevent silanol interaction. These commonly used solutions are not always successful, as they not only interact with the biologic, but are sometimes, not compatible. The non-ionic cyclodextrin itself does not cause protein aggregation but prevents the nonspecific binding or interaction of protein itself and thereby allowing for improved resolution, and accurate quantification of aggregates in antibodies, and peptides. The data on the separation in presence of cyclodextrin in the mobile phase showed higher peak resolution, improved peak shape, accurate apparent molecular weight, improved efficiency, and less peak tailing for biological products.Conclusion
Hydroxypropyl ß Cyclodextrin in the mobile phase, resulted improved SEC-HPLC resolution, and quantitation of aggregates in biologics by preventing the interaction of biologics to silanol of the commercial SEC-HPLC columns.7.
8.
Combined Targeting of BRAF and CRAF or BRAF and PI3K Effector Pathways Is Required for Efficacy in NRAS Mutant Tumors
下载免费PDF全文
![点击此处可从《PLoS Clinical Trials》网站下载免费的PDF全文](/ch/ext_images/free.gif)
9.
10.